Alnylam Pharmaceuticals
ALNY
#1097
Rank
$20.96 B
Marketcap
$156.50
Share price
-2.02%
Change (1 day)
-66.02%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company